Fredun Pharmaceuticals, 539730, FREDUN Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

2,373.46
54.16
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

2,530.88
0.02%
8.09

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

27.34
23.14
22.21

EBITDA CAGR (%)

10 Years
5 Years
3 Years

39.23
45.64
19.13

PAT CAGR (%)

10 Years
5 Years
3 Years

36.96
39.26
28.59

P:E (Median)

8 Years
5 Years
3 Years

37.04
37.04
37.04

P:BV (Average)

8 Years
5 Years
3 Years

3.02
3.02
3.02

EV:EBITDA (Average)

8 Years
5 Years
3 Years

10.89
10.89
10.89

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 228.25 119.85 90.45% 213.05 167.41 27.26% 160.92 102.70 56.69% 145.29 107.35 35.34%
Expenses 195.47 102.86 90.03% 183.92 149.97 22.64% 134.59 89.47 50.43% 122.96 93.40 31.65%
EBITDA 32.78 16.99 92.94% 29.13 17.44 67.03% 26.33 13.23 99.02% 22.33 13.95 60.07%
EBIDTM 14.36% 14.18% 13.67% 10.42% 16.36% 12.88% 15.37% 13.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 8.62 6.53 32.01% 14.48 8.15 77.67% 10.55 5.00 111.00% 7.73 5.31 45.57%
Depreciation 3.57 1.42 151.41% 3.11 1.25 148.80% 1.78 1.09 63.30% 1.60 1.06 50.94%
PBT 20.59 9.04 127.77% 11.53 8.04 43.41% 14.00 7.13 96.35% 13.01 7.58 71.64%
Tax 7.42 2.27 226.87% 0.47 0.97 -51.55% 3.52 1.80 95.56% 3.27 3.30 -0.91%
PAT 13.17 6.77 94.53% 11.06 7.07 56.44% 10.48 5.33 96.62% 9.73 4.27 127.87%
PATM 5.77% 5.64% 5.19% 4.22% 6.51% 5.19% 6.70% 3.98%
EPS 23.94 12.30 94.63% 20.12 12.86 56.45% 19.05 9.70 96.39% 17.69 7.77 127.67%

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 228.25 119.85 90.45% 213.06 167.41 27.27% 160.92 0.00 0 145.29 0.00 0
Expenses 195.51 102.86 90.07% 184.17 150.16 22.65% 134.59 0.00 0 122.96 0.00 0
EBITDA 32.74 16.99 92.70% 28.88 17.25 67.42% 26.33 0.00 0 22.33 0.00 0
EBIDTM 14.34% 14.18% 13.56% 10.30% 16.36% 0.00% 15.37% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 8.62 6.53 32.01% 14.48 8.15 77.67% 10.55 0.00 0 7.73 0.00 0
Depreciation 3.57 1.42 151.41% 3.15 1.84 71.20% 1.78 0.00 0 1.89 0.00 0
PBT 20.55 9.04 127.32% 11.25 7.26 54.96% 14.00 0.00 0 12.71 0.00 0
Tax 7.42 2.27 226.87% 0.47 1.26 -62.70% 3.52 0.00 0 3.27 0.00 0
PAT 13.13 6.77 93.94% 10.78 6.00 79.67% 10.48 0.00 0 9.43 0.00 0
PATM 5.75% 5.64% 5.06% 3.59% 6.51% 0.00% 6.49% 0.00%
EPS 7.94 4.78 66.11% 6.57 4.24 54.95% 6.51 0.00 0 6.66 0.00 0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 747.51 635.47 453.82 348.16 274.68 224.46 133.89 112.77 97.02 59.55 56.70 Net Sales Growth 50.31% 40.03% 30.35% 26.75% 22.37% 67.65% 18.73% 16.23% 62.92% 5.03% Cost Of Goods Sold 543.10 454.15 330.03 261.32 208.68 177.10 102.25 81.75 59.88 39.51 24.57 Gross Profit 204.41 181.32 123.78 86.83 65.99 47.35 31.65 31.02 37.14 20.04 32.12 GP Margin 27.35% 28.53% 27.28% 24.94% 24.02% 21.10% 23.64% 27.51% 38.28% 33.65% 56.65% Total Expenditure 636.94 544.31 401.17 310.17 246.90 210.55 124.55 104.44 86.99 53.84 53.37 Power & Fuel Cost - 6.19 5.45 4.47 3.37 3.49 2.94 3.10 2.75 1.60 1.64 % Of Sales - 0.97% 1.20% 1.28% 1.23% 1.55% 2.20% 2.75% 2.83% 2.69% 2.89% Employee Cost - 32.94 22.23 12.50 11.54 10.66 8.66 8.95 8.04 5.19 4.92 % Of Sales - 5.18% 4.90% 3.59% 4.20% 4.75% 6.47% 7.94% 8.29% 8.72% 8.68% Manufacturing Exp. - 12.77 15.25 10.34 7.24 4.41 3.13 3.58 4.03 1.21 15.32 % Of Sales - 2.01% 3.36% 2.97% 2.64% 1.96% 2.34% 3.17% 4.15% 2.03% 27.02% General & Admin Exp. - 29.85 21.50 15.85 10.81 8.72 5.47 5.19 7.13 3.57 3.34 % Of Sales - 4.70% 4.74% 4.55% 3.94% 3.88% 4.09% 4.60% 7.35% 5.99% 5.89% Selling & Distn. Exp. - 6.90 5.22 5.07 4.24 5.61 1.77 1.76 2.59 2.54 3.46 % Of Sales - 1.09% 1.15% 1.46% 1.54% 2.50% 1.32% 1.56% 2.67% 4.27% 6.10% Miscellaneous Exp. - 1.50 1.50 0.62 1.00 0.56 0.33 0.11 2.57 0.21 3.46 % Of Sales - 0.24% 0.33% 0.18% 0.36% 0.25% 0.25% 0.10% 2.65% 0.35% 0.19% EBITDA 110.57 91.16 52.65 37.99 27.78 13.91 9.34 8.33 10.03 5.71 3.33 EBITDA Margin 14.79% 14.35% 11.60% 10.91% 10.11% 6.20% 6.98% 7.39% 10.34% 9.59% 5.87% Other Income 0.00 3.66 2.45 0.92 1.82 1.63 1.40 0.52 0.58 0.16 1.91 Interest 41.38 39.32 22.38 13.65 9.28 4.78 4.37 4.47 3.12 1.95 1.87 Depreciation 10.06 7.91 4.45 3.80 2.81 2.16 2.00 1.88 1.33 1.29 1.14 PBT 59.13 47.58 28.27 21.45 17.51 8.60 4.37 2.49 6.16 2.64 2.23 Tax 14.68 14.38 7.46 5.83 6.70 2.26 1.19 0.59 1.70 0.89 0.80 Tax Rate 24.83% 30.22% 26.39% 27.18% 38.26% 26.28% 37.07% 23.69% 27.60% 33.71% 35.87% PAT 44.44 33.21 20.81 15.62 10.81 6.34 2.01 1.90 4.46 1.75 1.43 PAT before Minority Interest 44.44 33.21 20.81 15.62 10.81 6.34 2.01 1.90 4.46 1.75 1.43 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 5.95% 5.23% 4.59% 4.49% 3.94% 2.82% 1.50% 1.68% 4.60% 2.94% 2.52% PAT Growth 89.59% 59.59% 33.23% 44.50% 70.50% 215.42% 5.79% -57.40% 154.86% 22.38% EPS 80.80 60.38 37.84 28.40 19.65 11.53 3.65 3.45 8.11 3.18 2.60

Description TTM Mar 26 Mar 25
Net Sales - 635.47 453.82 Net Sales Growth - 40.03% Cost Of Goods Sold - 454.15 330.03 Gross Profit - 181.32 123.79 GP Margin - 28.53% 27.28% Total Expenditure - 544.56 401.36 Power & Fuel Cost - 6.19 5.45 % Of Sales - 0.97% 1.20% Employee Cost - 32.94 22.23 % Of Sales - 5.18% 4.90% Manufacturing Exp. - 12.77 15.25 % Of Sales - 2.01% 3.36% General & Admin Exp. - 30.11 21.57 % Of Sales - 4.74% 4.75% Selling & Distn. Exp. - 6.90 5.22 % Of Sales - 1.09% 1.15% Miscellaneous Exp. - 1.50 1.61 % Of Sales - 0.24% 0.35% EBITDA - 90.91 52.46 EBITDA Margin - 14.31% 11.56% Other Income - 3.66 2.45 Interest - 39.32 22.38 Depreciation - 8.25 5.04 PBT - 47.00 27.49 Tax - 14.38 7.75 Tax Rate - 30.60% 28.19% PAT - 32.62 19.74 PAT before Minority Interest - 32.62 19.74 Minority Interest - 0.00 0.00 PAT Margin - 5.13% 4.35% PAT Growth - 65.25% EPS - 59.31 35.89

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 278.71 141.40 121.47 96.38 68.06 43.07 41.32 38.99 22.16 7.26 Share Capital 5.47 4.72 4.70 4.53 4.43 3.99 3.99 3.99 3.43 4.87 Total Reserves 259.33 136.68 115.20 83.52 63.42 39.08 37.33 35.00 18.74 2.39 Non-Current Liabilities 67.11 17.93 19.30 21.25 45.18 32.09 14.07 12.51 4.06 8.37 Secured Loans 56.31 9.61 12.80 15.44 42.04 29.11 11.50 10.64 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 7.24 Long Term Provisions 4.26 3.83 2.37 1.96 1.71 1.60 1.63 1.08 3.25 0.28 Current Liabilities 296.31 327.32 166.83 139.66 73.75 86.46 85.99 53.41 53.04 40.47 Trade Payables 87.47 144.76 62.95 59.34 48.62 59.96 46.22 33.70 38.92 22.83 Other Current Liabilities 53.22 25.57 11.59 8.31 11.62 14.84 13.79 8.94 1.33 7.75 Short Term Borrowings 146.08 149.87 86.76 67.71 10.72 10.53 23.41 8.63 9.90 7.58 Short Term Provisions 9.54 7.12 5.54 4.29 2.79 1.13 2.57 2.13 2.89 2.31 Total Liabilities 642.13 486.65 307.60 257.29 186.99 161.62 141.38 104.91 79.26 56.10 Net Block 118.23 52.57 46.57 38.93 32.34 30.35 30.97 31.35 16.28 20.50 Gross Block 147.00 73.42 69.26 51.54 42.14 37.99 36.61 35.11 25.00 27.93 Accumulated Depreciation 28.77 20.85 22.69 12.61 9.80 7.64 5.64 3.76 8.71 7.43 Non Current Assets 143.89 64.40 50.46 41.07 34.34 31.54 32.05 32.39 27.78 20.85 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 11.15 0.00 Non Current Investment 2.02 1.51 0.06 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 12.43 4.07 3.36 2.13 2.00 1.18 1.08 1.03 0.35 0.35 Other Non Current Assets 11.21 6.25 0.46 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 498.24 422.25 257.14 216.21 152.65 130.08 109.32 72.52 51.48 35.24 Current Investments 0.00 0.00 0.75 0.31 0.06 0.06 0.05 0.00 0.00 0.00 Inventories 269.80 239.89 175.00 150.12 46.46 67.57 50.46 40.78 18.43 6.94 Sundry Debtors 92.69 177.12 64.85 34.56 90.27 41.08 38.97 17.78 15.26 20.38 Cash & Bank 64.95 0.28 1.35 3.44 2.07 1.13 3.06 1.47 1.45 0.75 Other Current Assets 70.80 3.14 1.44 0.75 13.78 20.25 16.78 12.49 16.35 7.18 Short Term Loans & Adv. 63.72 1.82 13.76 27.03 13.20 19.89 16.49 0.75 7.70 6.31 Net Current Assets 201.93 94.93 90.31 76.55 78.90 43.63 23.33 19.11 -1.56 -5.23 Total Assets 642.13 486.65 307.60 257.28 186.99 161.62 141.37 104.91 79.26 56.09

Description Mar 26 Mar 25
Shareholder's Funds 278.11 141.38 Share Capital 5.47 4.72 Total Reserves 258.73 136.66 Non-Current Liabilities 67.11 17.93 Secured Loans 56.31 9.61 Unsecured Loans 0.00 0.00 Long Term Provisions 4.26 3.83 Current Liabilities 296.86 328.10 Trade Payables 87.58 144.77 Other Current Liabilities 53.29 25.60 Short Term Borrowings 146.45 150.61 Short Term Provisions 9.54 7.12 Total Liabilities 642.08 487.41 Net Block 118.26 52.92 Gross Block 148.12 74.53 Accumulated Depreciation 29.86 21.61 Non Current Assets 143.91 60.21 Capital Work in Progress 0.00 0.00 Non Current Investment 2.01 1.50 Long Term Loans & Adv. 12.43 5.03 Other Non Current Assets 11.21 0.76 Current Assets 498.17 427.20 Current Investments 0.00 0.00 Inventories 269.80 239.89 Sundry Debtors 92.69 177.12 Cash & Bank 64.98 5.22 Other Current Assets 70.70 3.14 Short Term Loans & Adv. 63.62 1.83 Net Current Assets 201.31 99.11 Total Assets 642.08 487.41

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 16.44 -20.98 -0.44 -14.41 -2.38 0.17 -10.64 0.84 17.30 3.97 PBT 35.27 28.27 21.45 17.46 8.58 2.01 2.35 6.18 1.75 2.23 Adjustment 45.82 27.00 16.77 11.70 7.82 8.65 6.03 2.08 2.67 2.00 Changes in Working Capital -64.66 -76.25 -38.66 -43.57 -18.77 -10.50 -19.02 -7.43 12.88 -0.25 Cash after chg. in Working capital 16.44 -20.98 -0.44 -14.41 -2.38 0.17 -10.64 0.84 17.30 3.97 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -73.58 -5.99 -7.64 -9.40 -4.14 -1.39 -1.49 -5.25 -8.21 -7.13 Net Fixed Assets -73.58 -4.16 -17.72 -9.40 -4.15 -1.38 -1.50 1.04 -8.22 -7.13 Net Investments -0.51 -0.70 -0.50 -0.25 0.00 -0.01 -0.05 0.00 0.00 0.00 Others 0.51 -1.13 10.58 0.25 0.01 0.00 0.06 -6.29 0.01 0.00 Cash from Financing Activity 121.82 25.90 5.99 25.18 7.47 -0.71 13.73 4.43 -8.38 2.52 Net Cash Inflow / Outflow 64.67 -1.07 -2.08 1.36 0.94 -1.93 1.59 0.01 0.70 -0.64 Opening Cash & Equivalents 0.28 1.35 3.44 2.07 1.13 3.06 1.47 1.45 0.75 1.39 Closing Cash & Equivalent 64.95 0.28 1.35 3.44 2.07 1.13 3.06 1.47 1.45 0.75

Description Mar 26 Mar 25
Cash From Operating Activity 11.90 -16.60 PBT 34.68 27.49 Adjustment 46.16 27.59 Changes in Working Capital -68.94 -71.68 Cash after chg. in Working capital 11.90 -16.60 Interest Paid 0.00 0.00 Tax Paid 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 Extra & Other Items 0.00 0.00 Cash From Investing Activity -73.59 -6.35 Net Fixed Assets -73.58 Net Investments -0.51 Others 0.50 Cash from Financing Activity 121.45 26.65 Net Cash Inflow / Outflow 59.76 3.70 Opening Cash & Equivalents 5.22 1.52 Closing Cash & Equivalent 64.98 5.22

Financial Ratios

Standalone /

Consolidated

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 161.29 99.82 255.15 194.27 153.07 107.96 103.57 97.73 64.71 20.14 ROA 5.88% 5.24% 5.53% 4.86% 3.63% 1.33% 1.54% 4.84% 2.59% 2.88% ROE 16.35% 15.93% 15.03% 13.86% 11.42% 4.77% 4.74% 14.59% 13.02% 33.88% ROCE 21.50% 18.94% 17.13% 17.64% 13.15% 9.53% 10.36% 20.56% 15.90% 18.16% Fixed Asset Turnover 5.77 6.36 5.76 5.86 5.60 3.59 3.14 3.23 2.25 2.33 Receivable days 77.49 97.31 52.11 82.94 106.79 109.11 91.85 62.16 109.23 102.30 Inventory Days 146.38 166.84 170.43 130.61 92.72 160.89 147.66 111.37 77.73 55.39 Payable days 93.32 114.86 85.40 94.41 111.88 189.53 178.44 158.25 217.97 146.17 Cash Conversion Cycle 130.54 149.30 137.13 119.14 87.63 80.47 61.07 15.28 -31.02 11.52 Total Debt/Equity 0.84 1.18 0.88 0.98 0.78 0.92 0.84 0.49 0.45 2.53 Interest Cover 2.21 2.26 2.57 2.89 2.80 1.73 1.56 2.97 2.36 2.19

Description Mar 26 Mar 25
Book Value (Rs.) 160.92 99.81 ROA 5.78% 4.05% ROE 16.09% 13.96% ROCE 21.34% 16.16% Fixed Asset Turnover 5.71 6.09 Receivable days 77.49 142.46 Inventory Days 146.38 192.94 Payable days 93.37 160.10 Cash Conversion Cycle 130.49 175.29 Total Debt/Equity 0.84 1.18 Interest Cover 2.20 2.23

Top Investors:

bank of india

nav capital vcc - nav capital emerging star fund

llp

Annual Reports:

News Update:

Fredun Pharma - Quarterly Results
6th Aug 2026, 00:00 AM

Read More
Fredun Pharmaceuticals launches Hormone Range Products
18th May 2026, 17:16 PM

The initiative marks Fredun’s strategic entry into a rapidly expanding, high-value healthcare segment
Read More
Fredun Pharmaceuticals launches cellular longevity dedicated platform ‘Daulcel’
16th May 2026, 10:04 AM

The launch marks another strategic step in its expansion into innovation-led and future-focused healthcare segments
Read More

Fredun Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

BSE: 539730 | NSE: FREDUN

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Top Investors:

Annual Reports:

News Update:

Fredun Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

BSE: 539730 | NSE: FREDUN

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Top Investors:

Annual Reports:

News Update: